Literature DB >> 2479272

Immunologic characterization of Ewing's sarcoma using mesenchymal and neural markers.

S Lizard-Nacol1, G Lizard, E Justrabo, C Turc-Carel.   

Abstract

The two most recent hypotheses about the histogenesis of Ewing's Sarcoma (ES) are that it has a mesenchymal or neuroectodermal origin. Immunologic markers specific to these two tissue origins were tested on cryostat sections from three primary tumors carrying the chromosomal translocation t(11;22)(q24;q12). Cell lines established in vitro from two of these three primary tumors were also analyzed. Using antibodies directed against neural components (neurone-specific-enolase [NSE], HNK-1, and neurofilament triplet proteins [NFTP]), positive reactions were observed in cells from two primary tumors and their corresponding cell lines. Results of electron microscopic examination of the primary tumors were compatible with the diagnosis of ES. When using antibodies directed against mesenchymal cell surface antigens (common leucocytes, Leu M1, Leu M2, and Leu M3), the weak positive reactions observed in the three primary tumors were attributed to lymphoid infiltrates within tumor cells. Six additional ES cell lines carrying the translocation t(11;22) were also analyzed by immunocytochemical and flow cytometry methods using antibodies directed against mesenchymal and neural components. Positive reactions were observed in all seven cell lines tested using antibodies directed against NSE, HNK-1, and 200 KD subunit of the NFTP, whereas negative reactions were obtained with Leu M2 antibody. These results are consistent with a neuroectodermal origin of ES cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479272      PMCID: PMC1880093     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

1.  Cell size, DNA, and cytokeratin analysis of human head and neck tumors by flow cytometry.

Authors:  J T Bijman; D J Wagener; J M Wessels; P van den Broek; F C Ramaekers
Journal:  Cytometry       Date:  1986-01

2.  Neuron-specific enolase and Leu-7 immunoreactive small round-cell neoplasm. The relationship to Ewing's sarcoma in bone and soft tissue.

Authors:  K Kawaguchi; M Koike
Journal:  Am J Clin Pathol       Date:  1986-07       Impact factor: 2.493

3.  Neurofilament protein abnormalities in PC12 cells: comparison with neurofilament proteins of normal cultured rat sympathetic neurons.

Authors:  V M Lee
Journal:  J Neurosci       Date:  1985-11       Impact factor: 6.167

4.  The neuroectodermal tumor of bone.

Authors:  R Jaffe; M Santamaria; E J Yunis; N H Tannery; R M Agostini; J Medina; M Goodman
Journal:  Am J Surg Pathol       Date:  1984-12       Impact factor: 6.394

5.  Immunohistochemical demonstration of neuron-specific enolase in neoplasms of the CNS and other tissues.

Authors:  S A Vinores; J M Bonnin; L J Rubinstein; P J Marangos
Journal:  Arch Pathol Lab Med       Date:  1984-07       Impact factor: 5.534

6.  Biological characterization of human bone tumors. VIII. Expression of HLA-DR antigens in bone tumors and tumor-like lesions.

Authors:  M Petzsch; J Vassallo; A Roessner; G Zwadlo; C Sorg; E Vollmer; E Grundmann
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

7.  Osteosarcomas and Ewing's sarcomas. Comparative immunocytochemical investigation of filamentous proteins and cell membrane determinants.

Authors:  T Löning; J Liebsch; G Delling
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

Review 8.  Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology.

Authors:  M Osborn; K Weber
Journal:  Lab Invest       Date:  1983-04       Impact factor: 5.662

9.  Neuroblastoma and the differential diagnosis of small-, round-, blue-cell tumors.

Authors:  T J Triche; F B Askin
Journal:  Hum Pathol       Date:  1983-07       Impact factor: 3.466

10.  HNK-1 antibody detects an antigen expressed on neuroectodermal cells.

Authors:  M Lipinski; K Braham; J M Caillaud; C Carlu; T Tursz
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

View more
  5 in total

1.  Neurogenic potential of Ewing's sarcoma cells.

Authors:  T Sugimoto; A Umezawa; J Hata
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

2.  CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis.

Authors:  Anna Rocchi; Maria Cristina Manara; Marika Sciandra; Diana Zambelli; Filippo Nardi; Giordano Nicoletti; Cecilia Garofalo; Stefania Meschini; Annalisa Astolfi; Mario P Colombo; Stephen L Lessnick; Piero Picci; Katia Scotlandi
Journal:  J Clin Invest       Date:  2010-02-08       Impact factor: 14.808

3.  HNK-1 glycan functions as a tumor suppressor for astrocytic tumor.

Authors:  Misa Suzuki-Anekoji; Masami Suzuki; Tatsuya Kobayashi; Yoshiko Sato; Jun Nakayama; Atsushi Suzuki; Xingfeng Bao; Kiyohiko Angata; Minoru Fukuda
Journal:  J Biol Chem       Date:  2011-07-22       Impact factor: 5.157

4.  Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2.

Authors:  E J Fellinger; P Garin-Chesa; T J Triche; A G Huvos; W J Rettig
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

5.  Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications.

Authors:  Joanna Przybyl; Katarzyna Kozak; Hanna Kosela; Slawomir Falkowski; Tomasz Switaj; Iwona Lugowska; Anna Szumera-Cieckiewicz; Konrad Ptaszynski; Beata Grygalewicz; Magdalena Chechlinska; Barbara Pienkowska-Grela; Maria Debiec-Rychter; Janusz A Siedlecki; Piotr Rutkowski
Journal:  Med Oncol       Date:  2014-07-10       Impact factor: 3.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.